Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Respiratory Medicine|July 2, 2013
Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs: a meta-analysis of 22 phase III randomized controlled trialsWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Breast (Edinburgh, Scotland)|August 21, 2012
Comparison between doublet agents versus single agent in metastatic breast cancer patients previously treated with an anthracycline and a taxane: a meta-analysis of four phase III trialsWei-Xiang Qi, Li-na Tang, Ai-na He, et al.
International Journal of Clinical Oncology|April 23, 2013
Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trialsWei-Xiang Qi, Li-Na Tang, Ai-Na He, et al.
Current Neuropharmacology|May 23, 2014
Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological EvidenceYuan Shi, Jing-Wen Dong, Jiang-He Zhao, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|August 12, 2006
[Application of monoclonal antibody immobilized polyurethane film for site-specific gene therapy]Lin-Hua Zhang, Cun-Xian Song, Man-Yan Wang, et al.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae|June 18, 2005
[Endovascular microcoil applied for gene delivery system]Lin Mei, Hong-fan Sun, Li-na Tang, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|August 7, 2012
BAP1 is a good prognostic factor in advanced non-small cell lung cancerLi-Hong Fan, Li-Na Tang, Lu Yue, et al.
Lung|June 20, 2012
Doublet versus single cytotoxic agent as first-line treatment for elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysisWei-Xiang Qi, Li-na Tang, Ai-na He, et al.
British Journal of Clinical Pharmacology|July 10, 2013
Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysisWei-Xiang Qi, Feng Lin, Yuan-Jue Sun, et al.
Japanese Journal of Clinical Oncology|March 28, 2012
Efficacy and safety of gemcitabine-docetaxel combination therapy for recurrent or refractory high-grade osteosarcoma in China: a retrospective study of 18 patientsWei-Xiang Qi, Ai-Na He, Li-Na Tang, et al.
Pageof 7